Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the upcoming presentation of six scientific posters at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) taking place May 10-13, 2014 in Barcelona, Spain.
“Eravacycline Protects in a Bacillus anthracis-Infected New Zealand White Rabbit Treatment Model” “We are excited to be presenting data on multiple antibiotic candidates at ECCMID this year,” said Guy Macdonald, President and CEO of Tetraphase.
Help employers find you! Check out all the jobs and post your resume.
